Brought to you by 
Ivax Diagnostics buys Sigma-Diagnostics product line
07 Dec 2022
Executive Summary
Ivax Diagnostics (diagnostic reagents and instrumentation) has acquired the global enzyme immunoassay (EIA) product line of Sigma Diagnostics (instruments and reagents) for about $2.25mm and the assumption of certain liabilities..
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ivax Diagnostics buys Sigma-Diagnostics product line
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice